dronabinol has been researched along with Uterine Cervical Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hinz, B; Ramer, R | 1 |
1 other study(ies) available for dronabinol and Uterine Cervical Neoplasms
| Article | Year |
|---|---|
Inhibition of cancer cell invasion by cannabinoids via increased expression of tissue inhibitor of matrix metalloproteinases-1.
Topics: Arachidonic Acids; Biocompatible Materials; Cannabinoid Receptor Antagonists; Cannabinoids; Cell Movement; Collagen; Cytological Techniques; Down-Regulation; Dronabinol; Drug Combinations; Female; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; HeLa Cells; Humans; Immunoblotting; Laminin; Lung Neoplasms; Matrix Metalloproteinase 1; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Neoplasm Invasiveness; p38 Mitogen-Activated Protein Kinases; Protein Kinase Inhibitors; Proteoglycans; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Reverse Transcriptase Polymerase Chain Reaction; RNA, Small Interfering; Signal Transduction; Tissue Inhibitor of Metalloproteinase-1; Transfection; TRPV Cation Channels; Uterine Cervical Neoplasms | 2008 |